Hyperfine, Inc.

Hyperfine, Inc. reported increased sales and an improved net loss per share for the second quarter and first half of 2026. Q2 sales grew to $3.904 million, while net loss per share improved to $(0.09). The company significantly bolstered its cash position to $43.458 million, primarily through $13.641 million in new debt and $11.375 million from an at-the-market offering. Additionally, Hyperfine achieved key regulatory milestones, including CE Mark and UKCA Mark approvals for its next-generation Swoop® scanner and Optive AI™ software in March 2026.

Hyperfine, Inc. reported a significant increase in total sales for Q1 2026, up 82.6% to $3.9 million, driven by strong device sales. The net loss narrowed to $(8.6) million from $(9.4) million in Q1 2025. The company also secured several regulatory approvals for its Swoop® system and Optive AI™ software in the US, EU, UK, and India, and obtained $13.6 million in net debt proceeds. Despite improved financials, the company continues to operate with a going concern warning.

Hyperfine, Inc. reported strong first quarter 2026 financial results, with revenue increasing 83% year-over-year to $3.90 million and gross margin improving to 51%. The company also reduced its net loss to $8.62 million from $9.42 million in Q1 2025. Key business achievements include international regulatory approvals, progress in clinical studies, and the launch of the Swoop® system in India. Additionally, Hyperfine secured $15.0 million in debt financing, extending its cash runway into 2028.